Dug a hole for themselves ol' IMU. What next is the question? CR sure.... 20-30 million? Extra qtr or two..... but costs running well into 2027. Whether you are a medical holder of this stock or not something is broken here and we have been told not to expect anything soon from last webinar.
While a few more complete response or PR/SD is great for trials and patients it won't stop the rot. We are not seeing the paradigm shift..... I'd imagine a paradigm shift being a stronger pool of patients that have all had complete responses.
IMU can be as excited as they like about the science and maybe I am too but they have bitten off more than they can chew with these extraordinary and much lauded trial designs.
While I may get hammered for being a tad negative what can anyone argue has been the big positives for the way finances and expenditure has been managed on all fronts including the trial designs ? Act like BP this lot but just haven't got the financial clout to achieve what they want except for BP style salaries ..... shame really . Maybe something happens out of thin air but shit that's a crap investment strategy from me.... built on HOPE.
IMU Price at posting:
2.4¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)